News
DCOY
3.110
-19.22%
-0.740
Decoy Therapeutics Inducement Warrants Boost Near-Term Liquidity
TipRanks · 1d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 1d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 1d ago
Why Worthington Enterprises Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Benzinga · 2d ago
Press Release: Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release
Dow Jones · 2d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 2d ago
Crude Oil Down Over 1%; Thor Industries Shares Gain After Q4 Results
Benzinga · 2d ago
Why Is Penny Stock Decoy Therapeutics (DCOY) Up 48% Today?
TipRanks · 2d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 2d ago
Decoy Therapeutics To Exercise 1,184,434 Series B Warrants At $3.25/Share for ~$3.85M; Cuts Series A & C Warrant Prices To $3.25 And Issues 2,368,868 New Warrants At $3.25/Share
Benzinga · 2d ago
Dow Gains Over 100 Points; AutoZone Posts Upbeat Earnings
Benzinga · 2d ago
Decoy Expands Pan-Filovirus Efforts Through FDA Pathway; Stock Up
NASDAQ · 2d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 2d ago
Decoy Therapeutics Announces Its Exploring Non-Dilutive Federal Grants, Public Health Collaborations To Support Preclinical, Clinical Development Of Biodefense Pipeline
Benzinga · 2d ago
Decoy Therapeutics to explore pan-filovirus program via FDA Animal Rule pathway
TipRanks · 2d ago
Weekly Report: what happened at DCOY last week (0914-0918)?
Weekly Report · 3d ago
Decoy Therapeutics Shareholders Approve Key Capital Structure Changes
TipRanks · 09/15 21:54
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 09/15 21:06
Weekly Report: what happened at DCOY last week (0907-0911)?
Weekly Report · 09/14 09:30
Clinical Catalysts Drive Biotech Movers: Opus Genetics, Quantum & More
NASDAQ · 09/09 18:36
More
Webull provides a variety of real-time DCOY stock news. You can receive the latest news about DECOY THERAPEUTICS INC through multiple platforms. This information may help you make smarter investment decisions.
About DCOY
Decoy Therapeutics Inc., formerly Salarius Pharmaceuticals, Inc., is a preclinical-stage biotechnology company that is leveraging machine learning and artificial intelligence (AI) tools alongside high-speed synthesis techniques to design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The Company’s initial pipeline is focused on respiratory viruses and GI cancers. In parallel, the Company is advancing discovery programs, including multi-virus decoy candidates designed to address overlapping respiratory threats, and cell-based and organoid-level validation of novel G protein-coupled receptor (GPCR)-targeted drug candidates outside of antivirals.